Navigation Links
Cephalon Reports Record Earnings and Raises 2010 Guidance
Date:10/28/2010

FRAZER, Pa., Oct. 28 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today reported third quarter 2010 sales of $707.1 million, a 32 percent increase compared to sales of $535.2 million for the third quarter 2009.  Basic income per common share for the quarter was $1.76.  Excluding amortization expense and certain other items, basic adjusted income per common share for the quarter was $2.27, a 34 percent increase over the $1.70 for the third quarter of 2009.   Adjusted net income for the third quarter of 2010 was $170.7 million, a 35 percent increase over the $126.7 million for the third quarter of 2009.

Central nervous system (CNS) franchise sales were $354.3 million during the quarter, a 19 percent increase compared to the same period last year.  Pain franchise sales were $131.2 million, a 10 percent increase versus third quarter 2009.  Oncology franchise sales were $132.9 million, a 60 percent increase over the same period last year due to strong sales of TREANDA® (bendamustine HCL) for Injection.  Other product sales were $88.8 million, an increase of 153 percent versus third quarter of 2009 primarily due to the acquisition of Mepha in the second quarter of 2010.  

"We achieved record earnings and cash flow from operations in the quarter while continuing to expand our global product offerings," said Kevin Buchi, Chief Operating Officer. "Our robust cash flow generation gives us the flexibility to invest in our rich pipeline while continuing our active business development efforts, positioning us very well for the future."

The company is updating its guidance for full year 2010.  Total sales guidance is $2.69-$2.73 billion. This includes expected CNS franchise sales of $1.34-$1.37 billion, pain franchise sales of $510-$530 million, oncology franchise sales of $500-$520 million, and other product sales of
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
2. Cephalon Announces Chairman and CEO to Take Medical Leave of Absence
3. Cephalon Completes Acquisition of Arana Therapeutics
4. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
7. Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
8. Cephalons New Product Launches Pace Record 2008 Sales
9. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
10. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
11. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... The report “Adipic Acid Market by Application, ... Trends & Forecast to 2019” report analyzes the ... opportunities, and trends in different regions. , Browse ... through 217 slides and in-depth TOC on “Adipic ... 2019”., http://www.marketsandmarkets.com/Market-Reports/adipic-acid-269.html , Early buyers will receive ...
(Date:10/25/2014)... ViaDerma, Inc (OTCQB: ... to bringing new products to market, is committed ... has developed an innovative, patent-pending dual carrier transdermal ... of pharmaceutical active ingredients to penetrate the skin ... therapy. The transdermal delivery method also overcomes microbial ...
(Date:10/25/2014)... York, NY (PRWEB) October 23, 2014 ... announced the winners for the 2014 BioProcess International ... business strategies, social corporate responsibility and technology applications ... more effective treatments to a global patient base. ... by their peers during a very entertaining and ...
(Date:10/25/2014)... According to new market research report ... (Colocation, Enterprise, Telecom), by Design Types (Electrical, Mechanical), ... Tier 3, Tier 4) - Global Forecast to ... Data Center Construction Market into various segments with ... research report also identifies the factors driving this ...
Breaking Biology Technology:Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 2Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 3Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 4ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3BioProcess International Announces Winners of the 2014 BioProcess International Awards 2BioProcess International Announces Winners of the 2014 BioProcess International Awards 3BioProcess International Announces Winners of the 2014 BioProcess International Awards 4BioProcess International Announces Winners of the 2014 BioProcess International Awards 5Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 2Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 3Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 4
... ANNAPOLIS, Md. , Jan. 26 The following ... CEO of PharmAthene, regarding the Commission on the Prevention of ... Today,s Report Card by the Commission on the Prevention of ... warning that America still remains vulnerable to bioterrorism.  Our Nation,s ...
... , SHANGHAI , ... pharmaceutical R&D outsourcing Service Company in China , announced,that ... visited Sundia on January 22, 2010 . M.Raffarin, ... Serge,Feneuille and Mr. Erwan Davoux of ...
... , , , , ... /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ) ("3SBio" or "the Company"), ... and marketing,biopharmaceutical products, today announced that it will release financial,results for ... 8:00 PM (Eastern) on, Thursday, February 11, 2010 . , ...
Cached Biology Technology:Former French Prime Minister Jean-Pierre Raffarin Visits Sundia 23SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010 2
(Date:10/25/2014)... Oct.  22, 2014   MedNet Solutions , a ... management systems, is pleased to announce the 2014 ... – to be held in Bloomington, Minnesota ... to have record attendance and promises to be informative, ... The focus of the meeting is iMedNet™ ...
(Date:10/25/2014)... LONDON , Oct. 22, 2014 This ... is a relatively new space in heavy pursuit of ... are unique to miRNAs compared to other RNA components. ... make it a novel candidate for use as a ... pursuit of miRNA-based microarrays and diagnostics for the advancement ...
(Date:10/25/2014)... LONDON , Oct. 22, 2014 A ... in-depth analysis of the current and future genetic testing ... principles and types are covered in this report. On ... market trends; drivers; and existing strengths and challenges; forecast ... the market is likely to grow at a CAGR ...
Breaking Biology News(10 mins):MedNet Solutions To Host Third Annual iMedNet User Group Meeting 2MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview, Cambridge Healthtech Advisors 2Genetic Testing Market Outlook 2018 2
... pain more than men despite the popular notion that the ... differences in pain have found that not only do women ... also experience it in more bodily areas, more often and ... seem to be differences in how men and women think ...
... base are the guinea pigs for Oak Ridge National ... better determine whether a species has vanished. , After ... biologists were a bit concerned and were looking for ... ecologist and member of ORNL's Environmental Sciences Division. A ...
... a newly released method to analyze functional magnetic ... that the interconnections between different parts of the ... other findings answer longstanding debates about how brain ... are presented in the current (June 1) issue ...
Cached Biology News:Women feel more pain than men, research shows 2Women feel more pain than men, research shows 3Elusive salamanders have role in developing new sampling models 2Elusive salamanders have role in developing new sampling models 3Brain networks change according to cognitive task 2Brain networks change according to cognitive task 3